Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × NETWORK × Afatinib × Clear all

Phase

Status

Unknown 1 Terminated 1 Suspended 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

tocilizumab 1 lopinavir-ritonavir drug combination 1 azathiopurine 1 Surgical Procedures, Operative 1 Specimen Handling 1 Piperacillin, Tazobactam Drug Combination 1 Oxygen Inhalation Therapy 1 Methylprednisolone 1 Mercaptopurine 1 Lopinavir 1 Hydroxychloroquine 1 Heparin, Low-Molecular-Weight 1 Health Promotion 1 Educational Status 1 Azithromycin 1 Afatinib 1 Adrenal Cortex Hormones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02470065 2016-01-22

REMNANT

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Suspended

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡